https://insider.thefdagroup.com/archivedailyhttps://insider.thefdagroup.com/aboutweeklyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-march-20262026-04-03monthlyhttps://insider.thefdagroup.com/p/embedding-a-senior-quality-consultant2026-04-03monthlyhttps://insider.thefdagroup.com/p/why-embedding-a-senior-quality-consultant2026-03-31monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-ppi2026-03-31monthlyhttps://insider.thefdagroup.com/p/syncing-global-regulatory-filings2026-03-30monthlyhttps://insider.thefdagroup.com/p/a-podcast-appearance-leads-to-a-warning-letter2026-03-25monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-march-20262026-03-24monthlyhttps://insider.thefdagroup.com/p/an-fda-warning-letter-came-with-pictures2026-03-24monthlyhttps://insider.thefdagroup.com/p/hosting-a-gmp-audit2026-03-20monthlyhttps://insider.thefdagroup.com/p/navigating-regulatory-leadership2026-03-19monthlyhttps://insider.thefdagroup.com/p/whats-been-happening-at-the-fda-lately-20262026-03-18monthlyhttps://insider.thefdagroup.com/p/fda-adverse-event-monitoring-system-aems2026-03-17monthlyhttps://insider.thefdagroup.com/p/aica-security2026-03-16monthlyhttps://insider.thefdagroup.com/p/three-warning-letters-one-message2026-03-13monthlyhttps://insider.thefdagroup.com/p/aica-use-cases2026-03-11monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-mark-dacey2026-03-10monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-february-20262026-03-10monthlyhttps://insider.thefdagroup.com/p/march-2026-mocra-records-access2026-03-09monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-responding-to-fda-form-483-observations-at-the-conclusion-of-a-drug-cgmp-inspection2026-03-06monthlyhttps://insider.thefdagroup.com/p/getting-data-governance-for-regulatory2026-03-05monthlyhttps://insider.thefdagroup.com/p/aica-faq2026-03-09monthlyhttps://insider.thefdagroup.com/p/aica-is-officially-live-heres-everything2026-03-09monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-sterility2026-02-19monthlyhttps://insider.thefdagroup.com/p/quality-backlog-reduction2026-02-17monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-february-20262026-02-16monthlyhttps://insider.thefdagroup.com/p/building-resilient-biotech-teams2026-02-10monthlyhttps://insider.thefdagroup.com/p/industry-pushes-for-automatic-post-inspection-meetings2026-02-09monthlyhttps://insider.thefdagroup.com/p/15-takeaways-from-fdas-qmsr-implementation2026-02-06monthlyhttps://insider.thefdagroup.com/p/the-fda-opens-submissions-for-precheck2026-02-06monthlyhttps://insider.thefdagroup.com/p/february-2026-bayesian-methods-in2026-02-05monthlyhttps://insider.thefdagroup.com/p/fda-qmsr-is-here2026-02-03monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-january-20262026-02-02monthlyhttps://insider.thefdagroup.com/p/january-2026-ind-safety-reporting2026-02-02monthlyhttps://insider.thefdagroup.com/p/december-2025-biosimilar-ces-guidance2026-02-02monthlyhttps://insider.thefdagroup.com/p/november-2025-alternative-facility2026-02-02monthlyhttps://insider.thefdagroup.com/p/october-2025-fda-fy2024-pharmaceutical2026-02-02monthlyhttps://insider.thefdagroup.com/p/fda-qsit-replaced-qmsr2026-02-02monthlyhttps://insider.thefdagroup.com/p/september-2025-quality-management2026-02-01monthlyhttps://insider.thefdagroup.com/p/august-2025-fda-remote-regulatory2026-01-31monthlyhttps://insider.thefdagroup.com/p/july-2025-ich-m13b-bioequivalence2026-01-31monthlyhttps://insider.thefdagroup.com/p/june-2025-ich-q1-stability-guidelines2026-01-31monthlyhttps://insider.thefdagroup.com/p/may-2025-fdas-new-ai-guidance-for2026-01-31monthlyhttps://insider.thefdagroup.com/p/april-2025-special-edition-fda-downsizing2026-01-31monthlyhttps://insider.thefdagroup.com/p/march-2025-in-process-testing-guidance2026-01-31monthlyhttps://insider.thefdagroup.com/p/20-questions-your-quality-team-should-be-asking-part-22026-01-29monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-formal-dispute-505g2026-01-28monthlyhttps://insider.thefdagroup.com/p/what-a-strong-510k-submission-looks-like2026-01-27monthlyhttps://insider.thefdagroup.com/p/20-questions-your-quality-team-should-be-asking2026-01-29monthlyhttps://insider.thefdagroup.com/p/what-our-auditors-are-finding-lately-h2-20252026-01-23monthlyhttps://insider.thefdagroup.com/p/consultant-spotlight-neal-siegel2026-01-20monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-january-20262026-01-15monthlyhttps://insider.thefdagroup.com/p/fda-qmsr-town-hall2026-01-15monthlyhttps://insider.thefdagroup.com/p/10-questions-for-fda-qmsr-compliance2026-01-14monthlyhttps://insider.thefdagroup.com/p/building-phase-appropriate-quality2026-01-12monthlyhttps://insider.thefdagroup.com/p/processes-and-practices-applicable-to-bimo-inspections2026-01-09monthlyhttps://insider.thefdagroup.com/p/fda-drug-reviews-held-steady-in-20252026-01-08monthlyhttps://insider.thefdagroup.com/p/preparing-the-workforce-that-will-shape-pharma-future-ispe-mike-martin2026-01-06monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-envoy2025-12-19monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-december-20252025-12-17monthlyhttps://insider.thefdagroup.com/p/fda-removes-a-major-barrier-to-using-rwd2025-12-16monthlyhttps://insider.thefdagroup.com/p/drug-gmp-takeaways-from-fda-2025-warning-letters2025-12-15monthlyhttps://insider.thefdagroup.com/p/quality-management-system-regulation-technical-amendments2025-12-10monthlyhttps://insider.thefdagroup.com/p/how-to-build-and-sustain-a-quality-culture2025-12-09monthlyhttps://insider.thefdagroup.com/p/cder-warning-letters-jump-50-percent2025-12-09monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-503b-pq2025-12-08monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-ecopy-program-for-medical-device-submissions2025-12-04monthlyhttps://insider.thefdagroup.com/p/510k-best-practices2025-12-04monthlyhttps://insider.thefdagroup.com/p/from-molecule-to-market-a-commercial2025-12-02monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-cross-center-master-files2025-12-02monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-november-20252025-12-01monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-high-risk-component-testing2025-11-21monthlyhttps://insider.thefdagroup.com/p/how-regulators-are-bringing-ai-into2025-11-18monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-november-20252025-11-17monthlyhttps://insider.thefdagroup.com/p/5-critical-capa-lessons2025-11-13monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-identity-testing-expired-components2025-11-12monthlyhttps://insider.thefdagroup.com/p/tips-for-gcp-audits2025-11-14monthlyhttps://insider.thefdagroup.com/p/a-quick-explainer-on-the-tidmarsh-drama-at-fda2025-11-05monthlyhttps://insider.thefdagroup.com/p/new-mdr-ivdr-survey2025-11-04monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-october-20252025-11-03monthlyhttps://insider.thefdagroup.com/p/5-best-practices-for-audit-planning2025-11-06monthlyhttps://insider.thefdagroup.com/p/the-end-of-year-quality-crunch2025-10-30monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-qms-information2025-10-29monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-october-20252025-10-17monthlyhttps://insider.thefdagroup.com/p/a-pressure-tested-playbook-for-fda2025-10-17monthlyhttps://insider.thefdagroup.com/p/what-fdas-latest-otc-warning-letters2025-10-14monthlyhttps://insider.thefdagroup.com/p/a-case-study-in-fda-warning-letter-response-and-quality-system-overhaul-letter-response-and-quality-system-overhaul2025-10-08monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-data-integrity-and-investigation-discipline-issues-at-a-california-otc-drug-firm2025-10-07monthlyhttps://insider.thefdagroup.com/p/how-the-shutdown-is-affecting-the-fda2025-10-07monthlyhttps://insider.thefdagroup.com/p/leading-cross-functional-teams2025-10-06monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-september-20252025-10-06monthlyhttps://insider.thefdagroup.com/p/breaking-down-e21-including-pregnant-breastfeeding-women-in-clinical-trials2025-09-30monthlyhttps://insider.thefdagroup.com/p/mentorship-is-leadership-in-quality2025-09-29monthlyhttps://insider.thefdagroup.com/p/how-to-stay-ready-for-the-fda-when2025-09-26monthlyhttps://insider.thefdagroup.com/p/building-the-next-gen-lab-ai-in-a2025-09-19monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-september-20252025-09-17monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-alternative-tools2025-09-16monthlyhttps://insider.thefdagroup.com/p/a-few-more-insights-from-our-recent-audit-reports2025-09-12monthlyhttps://insider.thefdagroup.com/p/what-our-auditors-are-finding-lately-q2-20252026-02-03monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-e6r3-good-clinical-practice2025-09-09monthlyhttps://insider.thefdagroup.com/p/an-analysis-of-89-fda-crls2025-09-08monthlyhttps://insider.thefdagroup.com/p/how-to-build-high-performing-quality2025-09-09monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-august-20252025-09-02monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-jiangsu-kerbio2025-08-29monthlyhttps://insider.thefdagroup.com/p/takeaways-fda-report-on-state-of-pharma-quality-fy20242025-08-19monthlyhttps://insider.thefdagroup.com/p/the-4-cs-of-medtech-leadership-with2025-08-19monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-august-20252025-08-18monthlyhttps://insider.thefdagroup.com/p/fda-approval-showcase-early-20252025-08-08monthlyhttps://insider.thefdagroup.com/p/the-fda-announces-precheck2025-08-07monthlyhttps://insider.thefdagroup.com/p/quality-management-initiatives-in-the-pharmaceutical-industry-an-economic-perspective2025-08-05monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-medical-device-user-fee-small-business-qualification-determination2025-08-04monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-kabana-skin-care2025-08-01monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-july-20252025-07-31monthlyhttps://insider.thefdagroup.com/p/the-power-and-pitfalls-of-real-world2025-07-29monthlyhttps://insider.thefdagroup.com/p/selective-safety-data-collection-white-paper2025-07-24monthlyhttps://insider.thefdagroup.com/p/trump-gives-medical-device-sterilizers-two-years-to-comply-eto2025-07-23monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-glenmark2025-07-23monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-e21-inclusion-of-pregnant-and-breastfeeding-women-in-clinical-trials2025-07-18monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-whoop2025-07-17monthlyhttps://insider.thefdagroup.com/p/quality-is-not-a-cost-center-its-a-culture2025-07-16monthlyhttps://insider.thefdagroup.com/p/fda-inspection-readiness-high-purity-water-systems2025-07-16monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-july-20252025-07-15monthlyhttps://insider.thefdagroup.com/p/fda-publishes-200-complete-response-letters2025-07-11monthlyhttps://insider.thefdagroup.com/p/from-cost-center-to-value-driver2025-07-09monthlyhttps://insider.thefdagroup.com/p/is-conformity-bias-quietly-sabotaging2025-07-08monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-pediatric-dosing-protocols2025-07-07monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-503b-compounding-facility2025-07-03monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-june-20252025-07-01monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-conducting-remote-regulatory-assessments2025-06-27monthlyhttps://insider.thefdagroup.com/p/5-gmp-audit-questions-that-keep-catching-pharma-teams-off-guard2025-07-02monthlyhttps://insider.thefdagroup.com/p/q1-stability-testing-of-drug-substances-and-drug-products2025-06-25monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-requesting-post-warning-letter-meetings-under-gdufa2025-06-24monthlyhttps://insider.thefdagroup.com/p/fda-commissioners-national-priority-voucher-cnpv-program2025-06-19monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-breakdown-dtc-dental-device2025-06-19monthlyhttps://insider.thefdagroup.com/p/transfer-of-a-510k-clearance2025-06-18monthlyhttps://insider.thefdagroup.com/p/andas-pre-submission-facility-correspondence-related-to-prioritized-generic-drug-submissions2025-06-17monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-june-20252025-06-16monthlyhttps://insider.thefdagroup.com/p/510ks-fda-delays2025-06-16monthlyhttps://insider.thefdagroup.com/p/managing-royalties-in-biotech-pharma2025-06-09monthlyhttps://insider.thefdagroup.com/p/fda-elsa-ai-inspections2025-06-09monthlyhttps://insider.thefdagroup.com/p/fda-launches-elsa-its-ai-tool2025-06-05monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-may-20252025-06-02monthlyhttps://insider.thefdagroup.com/p/fda-warns-four-device-makers2025-05-31monthlyhttps://insider.thefdagroup.com/p/are-fda-workforce-cuts-slowing-down-fda2025-06-05monthlyhttps://insider.thefdagroup.com/p/takeaways-from-the-maha-report2025-06-04monthlyhttps://insider.thefdagroup.com/p/fda-warning-letter-kabe-labortechnik-gmbh2025-05-22monthlyhttps://insider.thefdagroup.com/p/gmp-compliance-in-503b-compounding2025-05-20monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-may-20252025-05-15monthlyhttps://insider.thefdagroup.com/p/fda-plans-to-roll-out-ai2025-05-14monthlyhttps://insider.thefdagroup.com/p/fda-changes-may-132025-05-13monthlyhttps://insider.thefdagroup.com/p/unannounced-fda-foreign-inspections2025-05-07monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-april-20252025-05-02monthlyhttps://insider.thefdagroup.com/p/fda-prereview-compliance2025-04-29monthlyhttps://insider.thefdagroup.com/p/fda-changes-april-252025-04-25monthlyhttps://insider.thefdagroup.com/p/quality-systems-fail-at-a-medical-device-firm2025-04-25monthlyhttps://insider.thefdagroup.com/p/ich-q12025-04-22monthlyhttps://insider.thefdagroup.com/p/15-audit-questions-part-32025-04-21monthlyhttps://insider.thefdagroup.com/p/fda-changes-april-182025-04-18monthlyhttps://insider.thefdagroup.com/p/ai-for-compliance2025-04-18monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-april-20252025-04-16monthlyhttps://insider.thefdagroup.com/p/15-audit-questions-part-22025-04-15monthlyhttps://insider.thefdagroup.com/p/fda-changes-april-102025-04-11monthlyhttps://insider.thefdagroup.com/p/fda-changes-april-92025-04-09monthlyhttps://insider.thefdagroup.com/p/fda-inspection-impact2025-04-08monthlyhttps://insider.thefdagroup.com/p/15-audit-questions-part-12025-04-08monthlyhttps://insider.thefdagroup.com/p/fda-changes-april-72025-04-08monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-march-20252025-04-01monthlyhttps://insider.thefdagroup.com/p/inside-3-fda-warning-letters-the2025-03-28monthlyhttps://insider.thefdagroup.com/p/tracking-major-changes-at-the-fda2025-04-08monthlyhttps://insider.thefdagroup.com/p/is-your-feedback-helping-or-hurting2025-03-26monthlyhttps://insider.thefdagroup.com/p/your-weekend-watch-leadership-and2025-03-21monthlyhttps://insider.thefdagroup.com/p/amazon-gets-an-fda-warning-letter2025-03-19monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-march-20252025-03-17monthlyhttps://insider.thefdagroup.com/p/what-to-do-if-you-recieve-a-fda-483-or-warning-letter2025-03-07monthlyhttps://insider.thefdagroup.com/p/martin-makary-senate-confirmation-hearing2025-03-07monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-february-20252025-03-04monthlyhttps://insider.thefdagroup.com/p/who-makes-this-drug-fda-issues-warning2025-02-28monthlyhttps://insider.thefdagroup.com/p/supplier-quality-audits2025-02-28monthlyhttps://insider.thefdagroup.com/p/february-20252026-02-03monthlyhttps://insider.thefdagroup.com/p/fda-drug-safety-report-fy242025-02-26monthlyhttps://insider.thefdagroup.com/p/3-minute-brief-key-updates-on-the2025-02-20monthlyhttps://insider.thefdagroup.com/p/fake-data-failed-tests-and-more-four2025-02-19monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-february-20252025-02-17monthlyhttps://insider.thefdagroup.com/p/fda-ldt-stage-1-compliance2025-02-18monthlyhttps://insider.thefdagroup.com/p/clinical-outsourcing-and-insourcing2025-02-14monthlyhttps://insider.thefdagroup.com/p/fda-uncovers-critical-manufacturing2025-02-13monthlyhttps://insider.thefdagroup.com/p/complying-with-21-cfr-211-1102025-02-12monthlyhttps://insider.thefdagroup.com/p/mastering-fda-and-ema-regulatory2025-02-10monthlyhttps://insider.thefdagroup.com/p/drug-manufacturing-inspection-readiness2025-03-02monthlyhttps://insider.thefdagroup.com/p/consultants-for-quality-system2025-02-06monthlyhttps://insider.thefdagroup.com/p/working-with-chinese-cro2025-02-05monthlyhttps://insider.thefdagroup.com/p/fda-it-operating-plan2025-02-05monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-january-20252025-02-04monthlyhttps://insider.thefdagroup.com/p/fda-inspection-readiness-eto-policy2026-02-03monthlyhttps://insider.thefdagroup.com/p/the-weekend-watch-developing-and2025-01-24monthlyhttps://insider.thefdagroup.com/p/a-few-quick-capa-tips2025-01-22monthlyhttps://insider.thefdagroup.com/p/quality-staff-augmentation-case-study2025-01-21monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-january-20252025-01-16monthlyhttps://insider.thefdagroup.com/p/the-fda-just-released-a-ton-of-guidance2025-01-07monthlyhttps://insider.thefdagroup.com/p/fda-gudid-guidance2025-01-03monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-december-20242025-01-02monthlyhttps://insider.thefdagroup.com/p/december-20242026-02-03monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-december-20242024-12-19monthlyhttps://insider.thefdagroup.com/p/are-you-ready-for-your-next-data2024-12-11monthlyhttps://insider.thefdagroup.com/p/inside-the-fda-warning-letter-over2024-12-10monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-fdas-new-bimo2024-12-09monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-fda-sets-new-expedited2024-12-05monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-pccps-for-ai-enabled2024-12-04monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-november-20242024-12-03monthlyhttps://insider.thefdagroup.com/p/one-of-the-most-concerning-warning2024-12-03monthlyhttps://insider.thefdagroup.com/p/november-2024-the-patient-safety2026-02-03monthlyhttps://insider.thefdagroup.com/p/the-smart-way-to-adopt-ai-in-clinical2024-11-22monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-faqs-on-developing2024-11-19monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-november-20242024-11-15monthlyhttps://insider.thefdagroup.com/p/demystifying-ai-in-life-sciences2024-11-15monthlyhttps://insider.thefdagroup.com/p/zero-to-qms-how-a-one-person-quality2024-11-15monthlyhttps://insider.thefdagroup.com/p/recent-warning-letters-reveal-systemic2024-11-14monthlyhttps://insider.thefdagroup.com/p/gao-fda-should-implement-strategies2026-02-09monthlyhttps://insider.thefdagroup.com/p/2025-audit-planning-5-things-you2024-11-12monthlyhttps://insider.thefdagroup.com/p/overcoming-key-quality-challenges2024-11-11monthlyhttps://insider.thefdagroup.com/p/sbom-data-normalization-in-medical2024-11-01monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-october-20242024-11-01monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-review-of-drug2024-10-29monthlyhttps://insider.thefdagroup.com/p/october-2024-the-regulatory-submissions2026-02-03monthlyhttps://insider.thefdagroup.com/p/streamlining-promotional-review-in2024-10-25monthlyhttps://insider.thefdagroup.com/p/a-simple-guide-to-annual-gmp-audit2024-10-22monthlyhttps://insider.thefdagroup.com/p/how-medipost-is-accelerating-us-clinical2024-10-22monthlyhttps://insider.thefdagroup.com/p/navigating-supplier-audits-in-japan2024-10-18monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-october-20242024-10-15monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-electronic-systems2024-10-11monthlyhttps://insider.thefdagroup.com/p/weekend-watch-inside-fda-pre-approval2024-10-04monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-our-top-10-takeaways2024-10-04monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-september-20242024-10-01monthlyhttps://insider.thefdagroup.com/p/answering-a-few-faqs-about-navigating2024-09-24monthlyhttps://insider.thefdagroup.com/p/the-anatomy-of-an-effective-supplier2024-09-20monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-september-20242024-09-18monthlyhttps://insider.thefdagroup.com/p/september-2024-how-to-build-a-robust2026-02-03monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-fda-revises-its-1932024-09-13monthlyhttps://insider.thefdagroup.com/p/cder-chief-on-inspection-backlog2024-09-13monthlyhttps://insider.thefdagroup.com/p/a-quick-note-on-finding-great-raqaclinical2024-09-06monthlyhttps://insider.thefdagroup.com/p/welcome-to-the-insider-newsletter-2142024-09-05monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-fda-revises-its2024-09-05monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-august-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/small-lots-big-risks-rethinking-statistical2024-08-29monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-predetermined2024-08-28monthlyhttps://insider.thefdagroup.com/p/10-takeaways-from-the-fdas-qmsr-medical2024-08-27monthlyhttps://insider.thefdagroup.com/p/4-best-practices-for-preventing-crls2024-08-27monthlyhttps://insider.thefdagroup.com/p/preparing-for-the-qmsr-a-comprehensive2026-01-14monthlyhttps://insider.thefdagroup.com/p/the-fda-is-building-an-active-postmarket2024-08-21monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-product-specific2024-08-20monthlyhttps://insider.thefdagroup.com/p/mastering-quality-metrics-a-guide2024-08-19monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-august-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/august-2024-inside-fdas-new-bimo2026-02-03monthlyhttps://insider.thefdagroup.com/p/how-performance-medtech-is-leveraging2024-08-12monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-postapproval-manufacturing2024-08-06monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-july-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/the-consultants-that-stayed-how-full2024-07-31monthlyhttps://insider.thefdagroup.com/p/the-fdas-fiscal-year-2025-user-fees2024-07-30monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-diversity-action2024-08-06monthlyhttps://insider.thefdagroup.com/p/a-quick-look-at-the-evolving-legal2024-07-25monthlyhttps://insider.thefdagroup.com/p/introducing-the-passionate-workforce2024-07-18monthlyhttps://insider.thefdagroup.com/p/applying-ai-in-the-life-sciences2024-07-16monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-july-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/july-2024-fda-to-use-more-remote2026-02-03monthlyhttps://insider.thefdagroup.com/p/fdas-cber-revises-its-sopp-for-processing2024-07-16monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-purpose-and-content2025-08-06monthlyhttps://insider.thefdagroup.com/p/navigating-challenges-in-raw-material2024-07-03monthlyhttps://insider.thefdagroup.com/p/what-the-overturning-of-chevron-could2024-07-02monthlyhttps://insider.thefdagroup.com/p/using-full-time-consultants-to-build2024-07-02monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-june-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-delaying-denying2024-06-26monthlyhttps://insider.thefdagroup.com/p/modernizing-clinical-quality-management2024-06-25monthlyhttps://insider.thefdagroup.com/p/building-and-leading-effective-quality2024-06-20monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-fda-issues-2-draft2024-06-19monthlyhttps://insider.thefdagroup.com/p/the-pharma-startup-playbook-advice2024-06-18monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-june-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/7-key-takeaways-from-fdas-fy20232024-06-14monthlyhttps://insider.thefdagroup.com/p/june-2024-implementing-ich-q2r2-validation2026-02-03monthlyhttps://insider.thefdagroup.com/p/the-passionate-workforce-is-out-now2024-06-11monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-may-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/may-2024-fda-revises-remote-mfg-guidance2026-02-03monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-mid-may-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/navigating-fda-regulations-for-samd2024-05-15monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-remanufacturing2024-05-13monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-rems-logic-model2024-05-08monthlyhttps://insider.thefdagroup.com/p/fda-officials-offer-tips-on-responding2024-05-07monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-april-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/crafting-quality-systems-for-each2024-04-30monthlyhttps://insider.thefdagroup.com/p/inside-the-fdas-final-rule-on-ldts2024-05-01monthlyhttps://insider.thefdagroup.com/p/how-to-write-effective-sops-a-q-and2024-04-26monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-electronic-submission2024-04-25monthlyhttps://insider.thefdagroup.com/p/april-2024-fda-draft-guidance-on2026-02-03monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-april-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/strategic-insights-from-novartiss2024-04-12monthlyhttps://insider.thefdagroup.com/p/guidance-breakdown-providing-regulatory2024-10-14monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-march-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/real-talk-on-remote-leadership-with2024-04-01monthlyhttps://insider.thefdagroup.com/p/the-passionate-workforce-how-to-create2024-07-09monthlyhttps://insider.thefdagroup.com/p/the-qmsr-explained-the-busy-raqa2024-03-21monthlyhttps://insider.thefdagroup.com/p/march-2024-the-2024-compliance-issue2026-02-03monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-march-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/how-to-use-interim-consultants-and2024-03-11monthlyhttps://insider.thefdagroup.com/p/5-commonly-overlooked-strategies2024-03-06monthlyhttps://insider.thefdagroup.com/p/the-fda-proposes-several-changes2024-03-06monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-key-information2024-03-05monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-february-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/the-fda-is-ramping-up-manufacturing2024-02-28monthlyhttps://insider.thefdagroup.com/p/10-things-you-should-be-doing-to2024-02-22monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-select-updates2024-02-21monthlyhttps://insider.thefdagroup.com/p/10-questions-to-ask-your-testing2024-02-20monthlyhttps://insider.thefdagroup.com/p/audit-and-fda-inspection-readiness2024-02-19monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-february-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-notifying2024-02-06monthlyhttps://insider.thefdagroup.com/p/mastering-the-tmf-ensuring-gcp-compliance2024-02-06monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-january-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/february-2024-issue-fda-finalizes2026-02-03monthlyhttps://insider.thefdagroup.com/p/breaking-the-fda-issues-its-qmsr2024-01-31monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-revising-anda2024-01-29monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-conducting2024-01-26monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-anda-submissionsamendment2024-01-26monthlyhttps://insider.thefdagroup.com/p/inside-the-fdas-plans-to-reform-its2024-01-23monthlyhttps://insider.thefdagroup.com/p/january-2024-issue-fda-issues-new2026-02-03monthlyhttps://insider.thefdagroup.com/p/the-startups-guide-to-setting-up2024-01-18monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-january-20242024-09-06monthlyhttps://insider.thefdagroup.com/p/a-unique-look-inside-a-510k-development2024-01-16monthlyhttps://insider.thefdagroup.com/p/warning-letter-breakdown-clinical2024-01-09monthlyhttps://insider.thefdagroup.com/p/a-former-fda-digital-health-staffer2024-01-04monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-reformulating2024-01-04monthlyhttps://insider.thefdagroup.com/p/a-few-iso-13485-and-iso-14971-questions2024-01-03monthlyhttps://insider.thefdagroup.com/p/fdas-year-end-guidance-drop-a-detailed2023-12-29monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-december-20232023-12-22monthlyhttps://insider.thefdagroup.com/p/december-2023-issue-fda-updates-policies2026-02-03monthlyhttps://insider.thefdagroup.com/p/a-blueprint-for-quality-culture-with2023-12-20monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-december-20232023-12-15monthlyhttps://insider.thefdagroup.com/p/an-fda-inspection-survival-guide2023-12-14monthlyhttps://insider.thefdagroup.com/p/clinical-data-standards-in-focus2023-12-13monthlyhttps://insider.thefdagroup.com/p/new-study-finds-fdas-inspection-pause2023-12-11monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-verification2023-12-08monthlyhttps://insider.thefdagroup.com/p/fdas-proposed-rule-to-regulate-ldts2023-12-07monthlyhttps://insider.thefdagroup.com/p/aligning-with-last-years-csa-guidance2023-12-04monthlyhttps://insider.thefdagroup.com/p/warning-letter-breakdown-poor-complaint2023-12-01monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-november-20232023-11-30monthlyhttps://insider.thefdagroup.com/p/november-2023-issue-fda-issues-guidance2026-02-03monthlyhttps://insider.thefdagroup.com/p/catch-up-with-our-recent-issues-over2023-11-22monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-translating2023-11-22monthlyhttps://insider.thefdagroup.com/p/the-link-between-quality-culture2023-11-16monthlyhttps://insider.thefdagroup.com/p/a-few-thoughts-on-what-fdas-opq-re2023-11-15monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-november-20232023-11-15monthlyhttps://insider.thefdagroup.com/p/mastering-medical-device-supplier2023-11-09monthlyhttps://insider.thefdagroup.com/p/the-quality-leaders-q4-checklist2023-11-08monthlyhttps://insider.thefdagroup.com/p/recent-fda-enforcement-trends-with2023-11-03monthlyhttps://insider.thefdagroup.com/p/8-questions-to-ask-when-planning2023-11-02monthlyhttps://insider.thefdagroup.com/p/growing-your-career-in-raqa-with2023-11-02monthlyhttps://insider.thefdagroup.com/p/inside-fdas-proposed-rule-to-regulate2023-11-01monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-october-20232023-10-31monthlyhttps://insider.thefdagroup.com/p/october-2023-issue-fda-adopts-ichs2026-02-03monthlyhttps://insider.thefdagroup.com/p/how-to-develop-a-narrative-summary2023-10-27monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-remote-interactive2023-10-25monthlyhttps://insider.thefdagroup.com/p/5-things-raqa-leaders-should-look2023-10-23monthlyhttps://insider.thefdagroup.com/p/drug-delivery-system-innovation-and2023-10-20monthlyhttps://insider.thefdagroup.com/p/fda-guidance-breakdown-quality-considerations2024-01-02monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-october-20232023-10-16monthlyhttps://insider.thefdagroup.com/p/fda-updates-its-policies-for-reviewing2023-10-10monthlyhttps://insider.thefdagroup.com/p/motivating-technical-teams-in-the2023-10-10monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-september-20232023-09-29monthlyhttps://insider.thefdagroup.com/p/september-2023-issue-inside-fdas2026-02-03monthlyhttps://insider.thefdagroup.com/p/bonus-issue-inside-fdas-new-draft2023-09-22monthlyhttps://insider.thefdagroup.com/p/how-to-overcome-5-common-challenges2023-09-21monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-september-20232023-09-15monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-august-20232023-09-13monthlyhttps://insider.thefdagroup.com/p/august-2023-issue-ai-and-machine2023-08-29monthlyhttps://insider.thefdagroup.com/p/bonus-issue-gap-analysis-remediation2023-08-22monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-august-20232023-09-13monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-july-20232023-07-28monthlyhttps://insider.thefdagroup.com/p/the-critical-role-of-hyper-targeting2023-07-25monthlyhttps://insider.thefdagroup.com/p/july-2023-issue-fdas-draft-guidance2023-07-24monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-july-20232023-07-17monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-late-june-20232023-06-29monthlyhttps://insider.thefdagroup.com/p/june-2023-applying-fdas-final-ich2023-09-13monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-mid-june-20232023-06-15monthlyhttps://insider.thefdagroup.com/p/quality-management-review-benchmarking2023-06-06monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-may-20232023-06-01monthlyhttps://insider.thefdagroup.com/p/medical-device-risk-management2023-05-17monthlyhttps://insider.thefdagroup.com/p/the-compliance-issue2023-09-13monthlyhttps://insider.thefdagroup.com/p/introducing-our-functional-service2023-04-19monthlyhttps://insider.thefdagroup.com/p/rems-device-inspection-authority2023-09-13monthlyhttps://insider.thefdagroup.com/p/raqa-news-roll-march-20232023-03-28monthlyhttps://insider.thefdagroup.com/p/bonus-pai2023-11-29monthlyhttps://insider.thefdagroup.com/p/implementing-ich-q142023-04-21monthlyhttps://insider.thefdagroup.com/p/bonus-issue-top-5-year-trending-fda-20232023-02-10monthlyhttps://insider.thefdagroup.com/p/february-2023-issue-revised-compliance2023-03-07monthlyhttps://insider.thefdagroup.com/p/mailbag2023-01-30monthlyhttps://insider.thefdagroup.com/p/bonus-issue-inspection-related-policies2023-02-15monthlyhttps://insider.thefdagroup.com/p/january-2023-issue-alternative-cgmp2023-02-15monthlyhttps://insider.thefdagroup.com/p/resources2022-12-16monthlyhttps://insider.thefdagroup.com/p/december-2022-issue-reporting-cmc2023-02-14monthlyhttps://insider.thefdagroup.com/p/november-2022-issue-reviewing-rmps2023-02-14monthlyhttps://insider.thefdagroup.com/p/october-2022-issue-revisions-to-q9r12023-02-13monthlyhttps://insider.thefdagroup.com/p/september-2022-issue2023-02-12monthlyhttps://insider.thefdagroup.com/p/august-2022-issue-fda-resumes-inspections2023-02-12monthlyhttps://insider.thefdagroup.com/p/proposed-cgmp-requirements-for-compounding2023-02-10monthlyhttps://insider.thefdagroup.com/p/another-take-on-fdas-remote-inspection2023-02-10monthlyhttps://insider.thefdagroup.com/p/fda-ramps-up-inspections2023-02-10monthly